Document Report Card

Basic Information

ID: ALA1139904

Journal: Bioorg Med Chem Lett

Title: 2-hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors.

Authors: Li JJ, Wang H, Tino JA, Robl JA, Herpin TF, Lawrence RM, Biller S, Jamil H, Ponticiello R, Chen L, Chu CH, Flynn N, Cheng D, Zhao R, Chen B, Schnur D, Obermeier MT, Sasseville V, Padmanabha R, Pike K, Harrity T.

Abstract: A novel series of 2-hydroxy-N-arylbenzenesulfonamides were identified to be ATP-citrate lyase (ACL) inhibitors with compound 9 displaying potent in vitro activity (IC(50)=0.13 microM). Chronic oral dosing of compound 9 in high-fat fed mice lowered plasma cholesterol, triglyceride, and glucose, as well as inhibited weight gain.

CiteXplore: 17383874

DOI: 10.1016/j.bmcl.2007.03.017